MIT scientists have devised remotely controlled nanoparticles that, when pulsed with an electromagnetic field, release drugs to attack tumors.

The innovation, reported in the Nov. 15 online issue of Advanced Materials, could lead to the improved diagnosis and targeted treatment of cancer.
https://news.mit.edu/2007/nanodrugs-1120

“Recently, there has been increasing interest in developing methods where drug release from the injected or implanted delivery system can be controlled by an operator, perhaps via a remote device. Ideally, such systems could determine the time, duration, dosage, and even location of drug release, and could allow remote, non-invasive, repeatable, and reliable switching of therapeutic agent flux.2¬†These devices are beneficial to patients across a wide spectrum of ages, since they enable drug release profiles tailored to the specific therapy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500532/

PLGA-Based Drug Delivery Systems for Remotely Triggered Cancer Therapeutic and Diagnostic Applications:
https://www.frontiersin.org/articles/10.3389/fbioe.2020.00381/full


Open AccessReview
Key Points in Remote-Controlled Drug Delivery: From the Carrier Design to Clinical Trials
https://www.mdpi.com/1422-0067/22/17/9149/htm

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.